An Open-label, Randomised, Cross-over, Single Dose Study in Healthy Volunteers to Evaluate the Unit Dose Dry Powder Inhaler (UD-DPI) With Four Different Formulations for the Delivery of Fluticasone Furoate and to Compare the Pharmacokinetic Profile With the Fluticasone Furorate ELLIPTA Presentation
Phase of Trial: Phase I
Latest Information Update: 22 May 2017
At a glance
- Drugs Fluticasone furoate (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 19 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 09 Nov 2014 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 22 Aug 2014 New trial record